Related Experiment Video
Updated: Oct 4, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Resolving sex and gender bias in COVID-19 vaccines R&D and beyond
Lavanya Vijayasingham1, Shirin Heidari2,3, Jean Munro4
1Gender and Health Hub, United Nations University- International Institute for Global Health, Kuala Lumpur, Malaysia.
Abstract:
The influence of sex and gender in immune response and vaccine outcomes is established in many disease areas, including in COVID-19. Yet, there are notable gaps in the consideration of sex and gender in the analysis and reporting of COVID-19 vaccines clinical trial data. The push for stronger sex and gender integration in vaccines science should be championed by all researchers and stakeholders across the R&D and access ecosystem - not just gender experts. This requires joint action on the tactical framing of customized value propositions (based on stakeholder motivations), the stronger enforcement of existing regulation, tools, and commitments, and aligning the overall agenda to parallel calls on intersectionality, equity diversity and inclusion.
More Related Videos
Related Concept Videos
Bias in Epidemiological Studies
Microorganisms in Medicine and Therapeutics
Sexually Transmitted Infections
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Ethics in Research

